BREAKING NEWS:
Clinical Trial using Canady Helios™ Cold Plasma Therapy for Solid Tumors
FDA# G190165
Treatment of Triple-Negative Breast Cancer Cells with the Canady Cold Plasma Conversion System: Preliminary Results
X. Cheng, W. Rowe, L. Ly, A. Shashurin, T. Zhuang, S. Wigh, G. Basadonna, B. Trink, M. Keidar and J. Canady
Plasma 2018, 1, 218–228; doi:10.3390/plasma1010019
Read Full Publication
RECENT VIDEOS
The Canady Robotic Assisted SR-70 Surgical System #1
We are the Future
family of companies
The Canady Robotic Assisted SR-70 Surgical System #2
Cold Plasma Oncotherapeutics
doctor testimonials
VIEW USMI’s EDUCATIONAL AND CLINICAL VIDEO LIBRARY
LATEST POSTS
US Medical Innovation to Present at the Baird 2019 Global Healthcare Conference
August 27, 2019 10:00 AM Eastern Daylight Time
TAKOMA PARK, MD.– US Medical Innovations, LLC (USMI), a U.S. FDA registered life science, biomedical and robotic device company (a subsidiary of US Patent Innovations, LLC), announced today that Jerome Canady MD, Chief Executive Officer, USMI will be presenting at the Baird 2019 Global Healthcare Conference on Thursday, September 5 from 9:40 to 10:10 AM in the Morgan Suite at the Intercontinental New York Barclay, New York, NY.
USMI currently has products in over 100 hospitals world-wide and this Fall is scheduled to start the first clinical trial in the U.S. to evaluate the its Canady Cold Plasma™ Technology for the treatment of cancer.
A live audio webcast of the conference presentation, along with the accompanying presentation materials, will be made available through a link on the USMI website at www.usmedinnovations.com/upcoming-events or at http://wsw.com/webcast/baird56/umi/
_ _ _ _ _ _ _ _ _ _ _ _
About US Medical Innovations
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science, biomedical and robotic device company. USMI is dedicated to expanding the boundaries of plasma medicine for the treatment of cancer and pioneering new surgical and robotic technologies that advance patient outcomes and improve human lives.
Contact:
Kenniah Chestnut, Esq
6930 Carroll Ave.
Takoma Park, MD 2091
301-270-0147
KChestnut@usmedinnov.com
www.usmedinnovations.com
August 27, 2019 10:00 AM Eastern Daylight Time
TAKOMA PARK, MD.– US Medical Innovations, LLC (USMI), a U.S. FDA registered life science, biomedical and robotic device company (a subsidiary of US Patent Innovations, LLC), announced today that Jerome Canady MD, Chief Executive Officer, USMI will be presenting at the Baird 2019 Global Healthcare Conference on Thursday, September 5 from 9:40 to 10:10 AM in the Morgan Suite at the Intercontinental New York Barclay, New York, NY.
USMI currently has products in over 100 hospitals world-wide and this Fall is scheduled to start the first clinical trial in the U.S. to evaluate the its Canady Cold Plasma™ Technology for the treatment of cancer.
A live audio webcast of the conference presentation, along with the accompanying presentation materials, will be made available through a link on the USMI website at www.usmedinnovations.com/upcoming-events or at http://wsw.com/webcast/baird56/umi/
_ _ _ _ _ _ _ _ _ _ _ _
About US Medical Innovations
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science, biomedical and robotic device company. USMI is dedicated to expanding the boundaries of plasma medicine for the treatment of cancer and pioneering new surgical and robotic technologies that advance patient outcomes and improve human lives.
Contact:
Kenniah Chestnut, Esq
6930 Carroll Ave.
Takoma Park, MD 2091
301-270-0147
KChestnut@usmedinnov.com
www.usmedinnovations.com
U.S. Medical Innovations LLC (USMI) and the Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI/ABTS) led the team and are sponsoring the clinical trial...
Treat cancer with cold plasma? Purdue aerospace engineer helps bring first clinical trial
Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration for first-ever use in a clinical trial.
purdue.edu
what’s next? SUBSCRIBE
Keep up-to-date with the latest news at US Medical Innovations
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science and biomedical device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives.